HALO BIO RNAI THERAPEUTICS INC has a total of 22 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are BBHC CO LTD, NAKAYAMA TOMOKO and STEM CELL & REGENERATIVE MEDICINE INTERNATIONAL INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | China | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 2 | |
#6 | Canada | 2 | |
#7 | Brazil | 1 | |
#8 | Israel | 1 | |
#9 | Japan | 1 | |
#10 | Mexico | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Microorganisms | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Hauser Todd M | 14 |
#2 | Todd M Hauser | 4 |
#3 | Hauser Todd | 3 |
#4 | Lee Amy C H | 1 |
Publication | Filing date | Title |
---|---|---|
CN111212649A | Methods and compositions for aptamer-driven ground surface formation self-forming polynucleotide nanoparticles | |
CA2995995A1 | Polynucleotide nanoparticles for the modulation of gene expression and uses thereof | |
AU2013202315A1 | Nicked polynucleotide complexes for multivalent RNA interference | |
CA2764158A1 | Polynucleotides for multivalent rna interference, compositions and methods of use thereof | |
WO2009076321A2 | Compositions and methods for modulating gene expression using asymmetrically-active precursor polynucleotides |